Article

Telefonica is collaborating with Fundacion Vithas and Francisco de Vitoria University to utilize quantum computing for cancer drug development. This project, to be discussed at MWC26 Barcelona, employs a hybrid model of classical and quantum computing to create molecules that inhibit mutations responsible for various malignant tumors.

The use of quantum computing allows for a more efficient exploration of chemical combinations, reducing research times that would typically span years with conventional computing methods. The initiative reflects the practical application of quantum computing in healthcare and other sectors.